FMR LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,688
-99.9%
3,728
-99.8%
0.00%
-100.0%
Q2 2023$24,719,905
-24.6%
2,325,485
-40.9%
0.00%
+100.0%
Q1 2023$32,790,394
+17.1%
3,936,422
+29.7%
0.00%
-66.7%
Q4 2022$28,009,810
-31.5%
3,034,649
-4.6%
0.00%
-25.0%
Q3 2022$40,863,000
+4.3%
3,182,503
+7.3%
0.00%0.0%
Q2 2022$39,168,000
-33.0%
2,964,988
+6.8%
0.00%
-20.0%
Q1 2022$58,426,000
-4.7%
2,775,582
+8.6%
0.01%0.0%
Q4 2021$61,290,000
-1.8%
2,554,799
+4.2%
0.01%0.0%
Q3 2021$62,401,000
-13.0%
2,452,871
+15.1%
0.01%
-16.7%
Q2 2021$71,745,000
-35.8%
2,131,456
-25.9%
0.01%
-40.0%
Q1 2021$111,765,000
-49.9%
2,877,569
-20.1%
0.01%
-50.0%
Q4 2020$223,008,000
+242.9%
3,600,975
+85.4%
0.02%
+185.7%
Q3 2020$65,033,000
+253.6%
1,941,880
+151.6%
0.01%
+250.0%
Q2 2020$18,394,000
+72.2%
771,866
+65.5%
0.00%
+100.0%
Q1 2020$10,679,000
-32.0%
466,347
-15.9%
0.00%
-50.0%
Q4 2019$15,701,000
+64.9%
554,397
+25.1%
0.00%
+100.0%
Q3 2019$9,520,000
-49.8%
443,013
-31.8%
0.00%
-50.0%
Q2 2019$18,961,000650,0000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders